DOI:
10.1055/s-00000012
Endoscopy
LinksClose Window
References
Hapani S, Chu D, Wu S.
Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis.
Lancet Oncol 2009;
10: 559-568
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.